s6y

Evoke Pharma Inc

CIK
1403708
Industry
Pharmaceutical Preparations

Financials 50

  1. 10-Q Quarterly Report for period ending Sep 30, 2025
  2. 10-Q Quarterly Report for period ending Jun 30, 2025
  3. 10-Q Quarterly Report for period ending Mar 31, 2025
  4. 10-K Annual Report for period ending Dec 31, 2024
  5. 10-Q Quarterly Report for period ending Sep 30, 2024
  6. 10-Q Quarterly Report for period ending Jun 30, 2024
  7. 10-Q Quarterly Report for period ending Mar 31, 2024
  8. 10-K/A Annual Report for period ending Dec 31, 2023
  9. 10-K Annual Report for period ending Dec 31, 2023
  10. 10-Q Quarterly Report for period ending Sep 30, 2023

All 50 financials filings

News 197

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 197 news filings

Ownership 254

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 254 ownership filings

Prospectus 49

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. SC TO-T/A Third party tender offer statement
  7. SC TO-T/A Third party tender offer statement
  8. SC TO-T Third party tender offer statement
  9. SC TO-C Written communication relating to an issuer or third party tender offer
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 49 prospectus filings

Proxies 32

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEF 14A Definitive proxy statements
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 32 proxies filings

Other 83

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. SCHEDULE 13D/A
  3. EFFECT Notice of Effectiveness
  4. EFFECT Notice of Effectiveness
  5. EFFECT Notice of Effectiveness
  6. EFFECT Notice of Effectiveness
  7. EFFECT Notice of Effectiveness
  8. EFFECT Notice of Effectiveness
  9. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  10. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing

All 83 other filings